Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Ceapro Inc V.CZO

Ceapro Inc. is a Canada-based biotechnology company. The Company is involved in the development of extraction technology and the application of this technology to the production of extracts and active ingredients from oats and other renewable plant resources. Its primary business activities relate to the development and commercialization of natural products for personal care, cosmetic, human... see more

TSXV:CZO - Post Discussion

Ceapro Inc > A Reminder to Vote NO
View:
Post by Apostata on Mar 04, 2024 8:38am

A Reminder to Vote NO

Voting NO is our last opportunity to steer CZO away from a parasitic merger that would setup CZO as a permanent hobby horse for semi-retired Gilles Gagnon, who lacks the smarts, urgency and willpower to actually bring something to the market. If we merge w/ AEZS then our investment will be swallowed by a shadow company that produces nothing, just another retirement vehicle for Gilles, who will get to tell his fellow stamp collector friends how he has his very own company on NASDAQ.
Comment by prophetoffactz on Mar 04, 2024 9:26am
Apostata, "If we merge w/ AEZS then our investment will be swallowed by a shadow company that produces nothing..." As for the truth, AEZS's launch of its diagnostic for growth hormone deficiency in the adult market is accelerating and with the completion of the pediatric clinical trial anticipated at the end of last year upon approval the test could soon be launched into its most ...more  
Comment by Ciao on Mar 04, 2024 9:58am
It appears most of us have received the VOTING FORMS with the control numbers in the mail last Friday.  We have until 1 minute before midnight on March 7th to VOTE NO. No need to delay, we waited long enough to receive the voting forms, VOTE NO now.
Comment by Apostata on Mar 05, 2024 7:57am
Finally received the materials in the mail...three days before the deadline to vote.  You can't tell me this isn't intentional, and yet another reason to VOTE NO. 
Comment by Stinzo on Mar 05, 2024 8:43am
being a non-resident, I would have never gotten it... Thankfully I submitted special request and just received the codes needed to vote ... a bientot Gilles ... 
Comment by tigerpro on Mar 05, 2024 2:51pm
Hi Stinz,   How did you get the code by special request?    Pls teach the non-resident shareholders? Thanks.
Comment by Stinzo on Mar 05, 2024 3:16pm
Hi Tigerpro, you need to call your brokers non-resident desk and ask them to provide the control number in order to go on the proxy website and vote. I called yesterday and got it around 24 hours later by an email address of the broker. 
Comment by Ciao on Mar 05, 2024 9:22am
Blantant case of trying to suppress NO votes. Based on the banter here and likely work by their proxy solicitation agent, they know there is little support for this sham merger. OATS will be the deciding factor. Because most of us have received our voting info with less than 7 days to vote, they may be in violation of securities laws. At most they will get slapped but in case the vote is close ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities